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ABSTRACT
A phylogenetically conserved RNA structure within
the NS5B coding region of hepatitis C virus func-
tions as a cis-replicating element (CRE). Integrity of
this CRE, designated SL9266 (alternatively 5BSL3.2),
is critical for genome replication. SL9266 forms
the core of an extended pseudoknot, designated
SL9266/PK, involving long distance RNA–RNA inter-
actions between unpaired loops of SL9266 and dis-
tal regions of the genome. Previous studies demon-
strated that SL9266/PK is dynamic, with ‘open’ and
‘closed’ conformations predicted to have distinct
functions during virus replication. Using a combina-
tion of site-directed mutagenesis and locked nucleic
acids (LNA) complementary to defined domains of
SL9266 and its interacting regions, we have explored
the influence of this structure on genome translation
and replication. We demonstrate that LNAs which
block formation of the closed conformation inhibit
genome translation. Inhibition was at least partly
independent of the initiation mechanism, whether
driven by homologous or heterologous internal ri-
bosome entry sites or from a capped message. Pro-
vision of SL9266/PK in trans relieved translational
inhibition, and mutational analysis implied a mecha-
nism in which the closed conformation recruits a cel-
lular factor that would otherwise suppresses trans-
lation. We propose that SL9266/PK functions as a
temporal switch, modulating the mutually incompat-
ible processes of translation and replication.
INTRODUCTION
Hepatitis C virus (HCV) is member of the Flaviviridae fam-
ily, within the Hepacivirus genus, and is a major cause of
liver disease, estimated to infect over 170 million people
worldwide (1). The virus possesses a positive-sense, single-
stranded RNA genome ∼9.6 kb in length encoding a single
open reading frame (ORF) flanked by 5′ and 3′ non-coding
regions (NCRs) (Figure 1A). The 5′NCR and adjacent
ORF incorporates an internal ribosome entry site (IRES;
nucleotides 39–371) essential for translation initiation by di-
rect recruitment of the 40S ribosomal subunit to the AUG
start codon (2–5). HCV RNA genomes are multifunctional
molecules, acting as a template for both translation and
replication. The initial translation events are essential for
subsequent replication, through the production of non-
structural proteins including the RNA-dependent RNA
polymerase (RdRp). Following early translation events
HCV genomic RNA is used as a template to generate
a double-stranded replication intermediate, the negative-
strand of which acts as a template for production of further
positive-sense daughter molecules. Viruses, including pre-
sumably HCV, have evolved many ways to control the key,
yet mutually exclusive, processes of translation and replica-
tion within their life cycle. These include a variety of feed-
back loops dependent upon interaction of viral or cellu-
lar proteins with sequence motifs, or more often secondary
structures, within the virus genome (6–8).
The HCV genome carries at least two distinct types of
RNA structure. The first, designated genome-scale ordered
RNA structure (GORS), is generally not phylogenetically
conserved (though the presence of structure is) and extends
throughout the genome (9). GORS is predicted to be in-
volved in subversion or evasion of the innate immune re-
sponse (10,11). In addition, the HCV genome contains a
number of discrete and highly conserved RNA structures,
primarily located in the 5′ and 3′NCRs and extending into
the adjacent coding region. Within the 5′NCR the IRES
consists of three RNA stem–loops (domains II, III and IV)
and a pseudoknot (at the base of stem III), essential for ri-
bosome recruitment and translation initiation (12–15). A
number of stem–loops within both the 5′NCR (domains I
and II) and the start of the ORF (designated SLV/SL47 and
SLVI/SL87 (16–18)), are also required for efficient genome
replication (19,20).
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Figure 1. (A) Schematic diagram of the genome of HCV JFH-1 (top) and Con1b-luc-rep (below) indicating the location of RNA stem–loop structures (SL)
using both standardised positional references and naming schemes from previous publications. (B) Schematic representation of the dynamic SL9266/PK
pseudoknot showing its open and closed conformations. A dashed line represents genome regions that switch between alternative conformations. (C)
Schematic of representation of SL9266 and SL9571 in Con1b showing individual nucleotides labelled with standardised positional references and locations
of the kissing loop (PK) and upstream interactions labelled in reverse camera. Dashed lines represents sequence regions not shown. (D) Table shows
schematic representations of SL9266/PK with antisense-LNA binding sites represented by red lines, non-specific linkers are shown as dashed red lines.
LNA-oligonucleotides are named for the upstream nucleotide to which they are predicted to bind and are preceded by a C (for Con1b) or J (for JFH-
1)––depending on which HCV isolate they target.
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The 3′NCR has roles in both initiation of anti-
genome synthesis and influencing IRES-mediated transla-
tion (21,22). It is composed of three distinct domains. A
hypervariable region directly downstream of the ORF fol-
lowed by a poly U/UC stretch of variable length and a
highly conserved domain at the 3′ terminus designated the
X-tail. The latter comprises three RNA stem–loops num-
bered SL9548, SL9571 and SL9061 (23) (alternatively des-
ignated SLI, SLII and SLIII respectively (24)). Within the
adjacent NS5B coding region there are at least five addi-
tional phylogenetically conserved stems loops designated
SL9033, SL9132, SL9217, SL9266 and SL9324 (17,18). Of
these, SL9266 (alternatively termed 5BSL3.2 (25) or SL-V
(26)) consists of a 12 nt terminal loop presented on upper
and lower hetero-duplexed domains with a sub-terminal 8
nt. bulge loop interrupting the 3′ proximal stem (Figure
1A).
It has been demonstrated, in both sub-genomic repli-
con and full length replicating virus systems, that disrupt-
ing base pairing within the duplexed stems of SL9266 pre-
vents or severely inhibits HCV replication (25,26). Conse-
quently, SL9266 is a cis-acting replicating element (CRE).
SL9266 does not act in isolation but as the core of a com-
plex tertiary structure, involving long-rangeRNA–RNA in-
teractions, essential for efficient virus replication. The 8 nt
bulge loop has been predicted to form several long dis-
tance RNA–RNA interactions, with genetic or biophysi-
cal evidence for binding to complementary sequences in
an upstream coding region centred on nt 9110 (23,27) or
to the single-stranded terminal loop of the IRES IIId do-
main (28,29). The terminal loop of the SL9266 forms a ter-
tiary ‘kissing loop’ interactionwith the terminal loop region
of SL9571 in the X-tail (30). SL9266 therefore forms the
core of an extended pseudoknot whichwe earlier designated
SL9266/PK (23). Additional studies suggest that these ter-
minal and bulge loop tertiary interactions are structurally
independent and that binding of one does not influence for-
mation of the other (23,31).
We previously published reverse genetic and biochemi-
cal structural data showing that the interactions involved
in the formation of SL9266/PK are dynamic (23). A com-
bination of biochemical mapping using SHAPE (selective
2′-hydroxyl acylation analysed by primer extension) and
phenotypic analysis of mutants, in both sub-genomic repli-
con and full length replicating virus systems, revealed that
SL9266/PK forms alternative closed and open conforma-
tions (Figure 1B), both of which are required for efficient
completion of the virus replication cycle. In the closed
conformation the ‘kissing loop’ interaction––between the
terminal loop of SL9266 and the sequences that occupy
the terminal loop of SL9571––prevents the formation of
the duplexed stem region of SL9571. Conversely, in the
open conformation the ‘kissing loop’ interaction is absent,
the terminal loops of both SL9266 and SL9571 are single
stranded and the duplexed stem of SL9571 can and does
form. SHAPE analysis of mutated molecules suggested that
the thermodynamic equilibriumbetween the two alternative
conformations favoured the open conformation in the geno-
type 1 Con1b andH77 isolates and the closed conformation
in genotype 2a JFH-1.
Here, we present further supporting evidence that
SL9266/PK functions as a dynamic riboswitch with open
and closed conformations. We demonstrate that transla-
tion from the HCV IRES is specifically enhanced by the
closed conformation while the open conformation is as-
sociated with reduced translation levels. We propose that
SL9266/PK functions as an essential temporal switch, in
which the open and closed conformationsmodulate themu-
tually incompatible translation and replication events criti-
cal for generation of progeny. These studies form the basis
for an improved understanding of HCV replication and fur-
ther define means to inhibit the function of a phylogenet-
ically conserved potential target for therapeutic interven-
tion.
MATERIALS AND METHODS
RNA stem–loop nomenclature
RNA stem–loops are designated according to the pub-
lished nomenclature of Kuiken et al. (32), essentially by
the position of the first 5′ paired nucleotide in the struc-
ture aligned and referenced to theH77 complete genome se-
quence (GenBank accession #AF011753) (23). Of relevance
to this report, stem–loop structures named 5BSL3.1–3.3,
SLVI–IV or SL9011, SL9061 and SL9118 are designated
here SL9217, SL9266 and SL9324 respectively. Likewise, the
three structures that together form the X-tail (SLIII, SLII
and SLI) are designated SL9548, SL9571 and SL9601 re-
spectively. The higher order structure formed by the ‘kiss-
ing loop’ interaction between the terminal loops of SL9266
and SL9571 has been designated SL9266/PK (23).
Design and nomenclature of locked nucleic acid (LNA) anti-
sense oligonucleotides
Antisense-LNA oligonucleotides (hereafter antisense-
LNAs; Exiqon) were designed to be complementary to
target sequences within genotype 1b (Con1b) or genotype
2a (JFH-1) SL9266/PK sequences (Figure 1C and Supple-
mentary data S1). Individual antisense-LNAs were either
complementary to specific subunit motifs of SL9266/PK or
to spatially separate structural motifs within different sub-
units of the higher order structure––in which case antisense
motifs were separated by non-specific linker sequences.
Antisense-LNAs were numbered for the position of the 5′
nucleotide (sense strand) of the target motif/s. They were
designed with a minimum of three 5′ and 3′ terminal LNA
nucleotides, with non-LNA nucleotides limited to four base
stretches and with similar thermodynamic and sequence
motif binding properties (LNA design tools, Exiqon).
The relative binding efficiency of antisense-LNAs and
their complementary RNA sequences was biochemically
quantified by gel shift assays (Supplementary data S2).
HCV cDNAplasmids, reporter construction andmutagenesis
The parental firefly luciferase-encoding Con1b sub-
genomic replicon pFK5.1 (termed here Con1b-luc-rep)
has been described previously (33) (Figure 1A). The
HCVcc––designated pFK-J6/JFH-1-C-846 (for con-
venience termed here as J6/JFH-1)––was generously
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provided by Takaji Wakita and NIH and has previously
been fully described (34) (Figure 1A). Replication-
incompetent derivatives of Con1b-luc-rep were generated
by a GDD>GND substitution, within the active site of
the NS5B polymerase as described previously (27). Renilla
luciferase RNA was generated from the cDNA plasmid
pRL (Promega).
A translation-only reporter construct for genotype 1b
(designated Con1b luc trans; Figure 3) was constructed by
overlap extension PCR of the Con1b-luc-rep cDNA tem-
plate. A fragment spanning the complete 5′NCR to the end
of firefly luciferase was amplified by PCR and joined to a
second PCR amplification product spanning the complete
NS5B and 3′NCR domains by overlap extension PCR. The
final overlap PCR product incorporated in sequential order
from the 5′ end; a unique Sac I restriction site, hammerhead
ribozyme sequence (which cleaves transcribed RNA imme-
diately upstream of the nucleotide 1 of the 5′NCR), com-
plete Con1b 5′NCR and the first 48 nts of the core coding
region in frame with firefly luciferase, an EMCV IRES (en-
cephalomyocarditis virus internal ribosome entry site) im-
mediately upstream of an AUG start codon, V5 peptide tag
fused in frame to the Con1b NS5B coding region, complete
3′NCR and a unique Spe I restriction site.
An alternative version of Con1b luc trans was
made, deficient in NS5B synthesis (designated
Con1b luc trans:NS5B; Figure 3), in which the third
codon position of the V5 sequence was mutated to a
stop codon (A2683T) to prevent translation of the tagged
NS5B coding region. Mutations were also made to remove
an in-frame AUG at codon 2 within the NS5B coding
region (A2725G+T2726C). Premature termination of NS5B
translation was confirmed by western blotting after in
vitro and in vivo translation (in Huh 7.5 cells and rabbit
reticulate lysate respectively) and compared to active NS5B
translation from a wild-type transcript (data not shown).
The overlap PCR generated fragment was incorporated
into pBluescript II KS (−) (Stratagene) downstream of
a bacteriophage T7 transcription promoter sequence (T7
sequence) between unique Sac I and Spe I restriction sites.
Two plasmids for constructing the JFH-1 based
translation-only reporter cDNA constructs were synthe-
sized by GeneArt (Life Technologies). The first carried a
unique Sac I restriction site, a 5′ hammerhead ribozyme
sequence, the complete JFH-1 5′NCR with the first 48
nts of the core coding region and 63 nts of firefly lu-
ciferase. The second plasmid contained the final 433
nts of the EMCV IRES, a V5 peptide tag sequence, the
complete NS5B coding region and 3′NCR of HCV JFH-1
followed by a unique Spe I restriction site. These two
plasmids were used to construct a JFH-1-based equivalent
of Con1b luc trans using standard cloning techniques
with the final bicistronic plasmid being designated JFH-
1 luc trans (Figure 3). As before, an alternative version
deficient in NS5B translation was also constructed and
designated JFH-1 luc trans:NS5B.
The HCV 5′NCR in Con1b luc trans:NS5B was re-
placed with the complete 5′NCR sequence of poliovirus
(type 3 Leon GenBank accession no. X00596.1), creat-
ing Polio luc trans:NS5B (Figure 3). A cDNA insert was
generated by overlap PCR incorporating in sequential or-
der a unique Sac I restriction site, the complete poliovirus
5′NCR and the 5′ 1159 nts of firefly luciferase. This frag-
ment was cloned into and replaced the equivalent regions
in Con1b luc trans:NS5B between the Sac I andXba I re-
striction sites; the 3′ NS5B coding region and 3′NCR from
Con1b remaining unchanged. Amono-cistronic translation
reporter lacking the EMCV IRES, V5 peptide sequence tag
and 5′ 321 nts of theNS5B encoding region was built (desig-
nated Con1b luc trans:EMCV (Figure 3), by deleting the
fragment between unique restriction sites Eag I and Zra I.
Con1b luc trans: 5′NCR+NS5B cDNA (Figure 3) was
transcribed from a Con1b luc trans: NS5B PCR product
template, initiating at the 5′ nucleotide position of firefly lu-
ciferase and terminated at the 3′ end of the 3′NCR. Muta-
tions were introduced using the Stratagene QuikChangeTM
system according to the manufacturers instructions, their
presence confirmed by DNA sequencing, and rebuilt into
the parental plasmid between unique restriction sites.
In vitro RNA transcription
One microgram of template linearized
with an appropriate enzyme (Sca I for
Con1b luc trans/:NS5B, Polio luc trans:NS5B and
Con1b luc trans:EMCV+:NS5B, BspH I for JFH-
1 luc trans:NS5B and Xba I for pRL) or terminated
with a 3′ cis-acting ribozyme (J6/JFH-1 plasmid) was used
to prime a T7 MEGAscript kit (Life Technologies), and
used according to the manufacturers instructions. PCR
products amplified with a sense primer containing a T7
promoter were generated as templates for transcription
of wild type and mutant NS5B-3′NCR RNA for trans
supplementation assays. Con1b luc trans:5′NCR RNA
was generated from a PCR amplified template as described
earlier, 250 ng was used as template for in vitro production
of 5′ [m7G(5′)ppp(5′)G] capped (m7G capped) RNA
using a T7 mMessage mMachine kit (Life Technologies)
according to the manufactures instructions. Following
transcription, residual DNA template was removed by
DNase 1 (Life Technologies) treatment and RNA purified
with an RNeasy mini-kit column (Qiagen). RNA integrity
was confirmed by denaturing agarose gel electrophoresis
and quantified by NanoDrop spectroscopy.
Cell culture and transfections
Monolayers of the human hepatoma cell line Huh 7.5 (a
generous gift from Charles Rice) were maintained in Dul-
becco’s modified minimal essential medium (DMEM) sup-
plemented with 10% (v/v) foetal bovine serum (FBS) (Life
Technologies), 1% non-essential amino acids, 2 mM L-
glutamine and 100 U penicillin/100 g streptomycin/ml
(DMEM P/S). Cells were passaged after trypsin/EDTA
treatment, seeded at dilutions of 1:3 to 1:5 and maintained
at 37◦C in 5% CO2.
Reporter transfection and analysis
Huh 7.5 cells were seeded in 24-well plates at ∼3 × 105
cells/well and maintained overnight in DMEM P/S before
RNA transfection using Lipofectamine 2000 (Life Tech-
nologies). Briefly, monolayers at ∼90% confluence were
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washed twice in phosphate buffered saline (PBS) before
adding 500 l of DMEM supplemented with 1% non-
essential amino acids and 2 mM L-glutamine before ad-
dition of 100 l of transfection medium in a dropwise
manner. Transfection medium was prepared according to
the manufacturer’s instructions with 2 l Lipofectamine
2000, 0.32 pmol of reporter RNA, 0.32 pmoles of renilla
luciferase RNA and made up to 100 l with Opti-Mem
reduced-serum media (Life Technologies). Where appro-
priate, antisense-LNA, scrambled LNA oligonucleotide or
in vitro synthesized SL9266/PK RNA, was included in
the transfection medium. After transfection, monolayers
were maintained for 6 h before being washed twice with
PBS, lysed with 0.5 ml Glo-Lysis Buffer (Promega) and
stored frozen prior to analysis using Dual-luciferase sub-
strate (Promega) and a Turner TL-20 luminometer. In the
case of Con1b-luc-rep, media was changed after 4 h, mono-
layers washed twice with PBS and replaced with 1 ml of
DMEM P/S. They were then maintained for 24 h before
harvesting and analysed as described earlier.
Virus analysis and quantification
Huh 7.5 cells were seeded in a 24-well plate at ∼3 × 105
cells/well and maintained overnight in DMEM P/S. The
following day monolayers were washed twice with PBS
and transfected with 300 nmol of antisense-LNA using
Lipofectamine 2000 as described earlier. Four hours post-
transfection monolayers were washed twice with PBS and
once with DMEM P/S before incubating for 2 h with 300
l of filtered J6/JFH-1 virus supernatant (2 × 102 ffu/ml).
Virus media was then removed, monolayers washed twice
with PBS and replaced with 1 ml DMEM P/S. Twenty four
hours after infection, monolayers were washed twice with
PBS, fixed with 1 ml 4% paraformaldehyde for 20 min, and
washed twice in PBS before permeabilization with 0.1%Tri-
ton PBS for 7 min with constant agitation. After a subse-
quent PBS wash infected cells were detected using a poly-
clonal sheep antibody to NS5A (NS5A; generously sup-
plied by Mark Harris) diluted 1:5000 in 10% FBS. After in-
cubation for 1 h. primary antibody was detected using an
AlexaFluor594-conjugated secondary anti-sheep antibody
(1:500 in 10% FBS; Invitrogen), washed in PBS and stored
under PBS containing 0.1% VECTASHIELD DAPI (Vec-
tor Laboratories) before analysis by UV microscopy. In-
fected foci were counted and expressed in focus forming
units per ml (ffu/ml).
Statistical analysis
Statistical analysis was carried out using two-tailed Stu-
dent’s t-tests for unpaired samples of equal variance. P val-
ues of ≤0.05 (*), ≤0.01 (**), ≤0.001 (***) and ≤0.0001
(****) were considered to represent degrees of significance.
RESULTS
Reverse genetic analysis has demonstrated that deletion or
mutation of base-pairing components within SL9266/PK
inhibit virus replication to varying degrees (23,27,30,35).
This effect has been observed for different genotypes and
in different assay systems, including sub-genomic replicons
and full-length virus (HCVcc), in both cell culture and an-
imal model systems. This phenotype may result from the
direct inhibition of replication per se or indirectly by the
inhibition of translation, resulting in the subsequent sup-
pression of replication. To investigate this further we stud-
ied the inhibitory influence of degradation resistant LNA
oligonucleotides complementary to features of SL9266/PK
on virus replication and translation, reasoning that a bound
LNA would interrupt the function of SL9266/PK. A range
of antisense-LNAs were designed to inhibit formation of
the pseudoknot, to simultaneously anneal to the upstream
and downstream components of SL9266/PK––mimicking
a locked closed conformation––or to block different poten-
tial sequence specific signal motifs (Figure 1C).
Steric hindrance of SL9266/PK: replicon and HCVcc pheno-
types
The effect of SL9266/PK antisense-LNAs on HCV repli-
cation was assayed in Huh 7.5 cells using a Con1b sub-
genomic replicon system 24 h post-transfection and ex-
pressed as a function of relative luciferase translation com-
pared to control assays lacking LNA-oligonucleotides (Fig-
ure 2A). Scrambled LNA-oligonucleotides or antisense-
LNAs targeting an unstructured region within the HCV
genome (C 9006) (17), upstream of SL9266/PK, were as-
sayed with no difference observed from untreated con-
trol assays. Antisense-LNAs specific to SL9266 domains
partially or completely involved in pseudoknot forma-
tion (LNAs C 9284 and C 9280–9298; Figure 1C) sup-
pressed replication by ∼75% and ∼80% respectively (P
≤ 0.0001). Specifically targeting components of SL9571
(LNAs C 9587 and C 9580) resulted in less––although still
statistically significant – repression of HCV replication.
Antisense-LNAs simultaneously targeting either the ter-
minal or bulge loops SL9266 and the terminal loop of
SL9571 (LNAs C 9280-9579 and C 9298-9579) inhibited
replication by ∼63% (P ≤ 0.001) and 75% respectively (P
≤ 0.0001). In contrast, antisense-LNAs designed to only
block SL9266 duplex-stem formation (LNA C 9263) or to
bind to the upstream region 9110, with which the bulge loop
of SL9266 interacts (LNA C 9106), had no statistically sig-
nificant effect on replication.
The structural dynamics of SL9266/PK differ between
the predominant HCV model systems (Con1b/H77 and
JFH-1) (23). To investigate whether there were also differ-
ences between the inhibitory effects of pseudoknot-specific
LNAs we additionally tested a subset of antisense-LNAs
specific for JFH-1 SL9266/PK. Their effect on full-length
J6/JFH-1 virus replication in the HCVcc system was as-
sayed by infection of LNA transfected cells, measured by
immunofluorescence 24 h post-infection and expressed in
terms of focus-forming units per ml (ffu/ml) compared to
controls lackingLNA-oligonucleotides (Figure 2B). Target-
ing the pseudoknot with antisense-LNAs designed to the
single-stranded loops and upper duplex of SL9266 (J 9282)
inhibited virus replication by ∼65% (P = 0.0011). Sin-
gle antisense-LNAs simultaneously targeting either the ter-
minal loop regions of SL9266 and SL9571 (J 9280–9579)
or the bulge loop of SL9266 and terminal loop region of
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Figure 2. The effect of SL9266/PK antisense-LNAs on replication and translation in Huh 7.5 cells of the Con1b-luc-rep sub-genomic replicon
and replication of J6/JFH-1 virus. Results represent the average of at least three independent assays, and are expressed as a percentage of control
transfections/infections lacking antisense-LNAs or scrambled LNA-oligonucleotides (error bars indicate the standard error from the mean and stars
the degrees of significance from untreated controls). (A) Con1b-luc-rep: Relative luciferase levels (Firefly/Renilla) were measured 24 h post-RNA trans-
fection. (B) J6/JFH-1 HCVcc: Replication was measured as focus forming units/ml (ffu/ml) 24 h post-infection in the presence of antisense-LNAs. (C)
Relative luciferase levels (Firefly/Renilla) from transfected Con1b-luc-rep RNA compared to a replication defective mutant bearing a GDD>GND mu-
tation within the active site of RdRp. Relative luciferase levels were measured 6 h post-transfection and expressed as a percentage of control transfections
for either the wild type (filled black bars) or GND mutant (open bars). Significance between corresponding wild type and GND mutants indicated.
SL9571 (J 9299–9579) both inhibited virus replication by
∼55% (P = 0.0032 and 0.0031 respectively). As demon-
strated in the genotype 1b system, an antisense-LNA, com-
plementary to an unstructured region of the virus genome
(J 9007), had no effect in virus replication.
These assays demonstrate that complementary oligonu-
cleotides targeting the phylogenetically conserved
SL9266/PK pseudoknot can inhibit genome replica-
tion. All antisense-LNAs were demonstrated to hybridize
to template molecules (Supplementary data S2) and no
correlation was observed between measured or predicted
annealing efficiencies and levels of inhibition. The absence
of inhibition––for example by C 9006––implies that the
inhibitory effect is not mediated by a simple block to
ribosome progression, or by an RNAi-type degradation of
the virus genome.
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Figure 3. Schematic diagrams of translation only reporter constructs. (i) Represents a bicistronic construct with the 5′NCR from HCV upstream of the
first 66 nucleotides of the HCV core coding region fused in frame to firefly luciferase. A downstream EMCV IRES initiates translation from the NS5B
coding region, which is upstream of the complete HCV 3′NCR (in NS5B versions NS5B is not translated due to a stop codon incorporated at the third
codon position, which is represented by the black triangle). Con1b and JFH-1 versions of this reporter were constructed and assayed. The Con1b reporter
construct was further modified by replacing the 5′NCRwith either an m7G cap (ii), a polio virus 5′NCR (iii) or by deleting the EMCV IRES and upstream
portion of NS5B (an in frame stop codon was incorporated into the 3′ truncated NS5B, represented by a black filled triangle) (iv).
Steric hindrance of SL9266/PK: translation reporter pheno-
type
Having demonstrated that targeting SL9266/PK blocks
HCV replication the impact on genome translation was
assayed (Figure 2C). Using a replication-defective sub-
genomic replicon bearing a GDD>GND substitution in
the NS5B polymerase active site, we investigated the influ-
ence on translation of a subset of LNAs earlier demon-
strated to have the greatest inhibitory effect on Con1b
replication. The effect of antisense-LNAs C 9280-9298 and
C 9298-9579 on luciferase translation from the GND mu-
tant, relative to controls lacking LNA-oligonucleotides, was
measured 6 h post-transfection and compared to an equiv-
alent parallel assay using replication competent replicons.
Antisense-LNAs complementary to SL9266/PK inhibited
luciferase translation from the GND mutant, which was
unaffected by the C 9006 control. Relative levels of lu-
ciferase inhibition from the GND mutant were indistin-
guishable from those observed for the parental (GDD)
replicon treated with the same oligonucleotides, suggesting
that SL9266/PK antisense-LNAs were specifically inhibit-
ing HCV translation rather than genome replication.
In order to further investigate the specific role of
SL9266/PK closed and open conformations in modulating
HCV IRES-initiated translation in the absence of genome
replication, we developed a panel of translation-only re-
porter plasmids (Figure 3). We used a bacteriophage T7
polymerase-transcribed bicistronic system in which the
upstream cistron was a firefly luciferase reporter gene,
translation of which was driven from an HCV IRES. A
second IRES––from encephalomyocarditis virus (EMCV)
(36)––recruited ribosomes to translate the downstream
cistron encoding the entire NS5B protein, with the RNA
transcript terminating at the 3′ end of the authentic HCV
3′ NCR. Variants of this bicistronic plasmid with either
Con1b- or JFH-1-derived HCV sequences were generated
(Con1b luc trans and JFH-1 luc trans respectively), with
alternative versions deficient inNS5B translation (:NS5B)
through incorporation of a termination codon near the start
of the ORF. Changes in levels of HCV IRES driven transla-
tion, when challenged with SL9266/PK-specific antisense-
LNAs, were expressed as a function of relative luciferase
expression 6 h post-transfection compared to assays lack-
ing LNAoligonucleotides. In preliminary assays we demon-
strated that NS5B translation in cis had no observable ef-
fect on HCV IRES-mediated translation or its inhibition,
with relative luciferase expression levels indistinguishable
between Con1b luc trans or JFH-1 luc trans and their as-
sociated NS5B versions (Supplementary data S3). Simi-
larly, NS5B expression in trans had no effect on transla-
tion inhibition by SL9266/PK antisense-LNAs (data not
shown).We therefore standardized on comparing luciferase
reporter activity from theNS5B variants of the bicistronic
system (Figure 4A).
Sequence-scrambled LNA oligonucleotides or antisense-
LNAs complementary to unstructured regions of the
Con1b genome (LNAC 9006) had no effect on translation.
Antisense-LNAs specific to domains of SL9266 involved in
pseudoknot formation (C 9284 and C 9280–9298) inhib-
ited HCV-IRES driven luciferase translation by >60% (P
≤ 0.0001) and >75% (P ≤ 0.0001) respectively. In contrast,
LNAs complementary to SL9571 (C 9587 and C 9580) had
a less-marked inhibitory effect of >25% (P ≤ 0.001) and
>50% (P ≤ 0.0001) respectively. LNAs designed to bridge
distinct domains of SL9266/PK, targeting either the termi-
nal (C 9280-9579) or bulge loop (C 9298–9579) of SL9266
and the terminal loop of SL9571, suppressed luciferase
translation from the HCV IRES by>60% (P≤ 0.0001) and
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Figure 4. Translation in Huh 7.5 cells from Con1b (Con1b luc trans:NS5B) and JFH-1 (JFH-1 luc trans:NS5B) translation-only reporter construct
RNA in the presence of SL9266/PKantisense-LNAs or scrambled LNA-oligonucleotides. Relative luciferase levels (Firefly/Renilla) weremeasured 6 hours
post-transfection. Results represent an average of three independent assays and are expressed as a percentage of control transfections lacking antisense-
LNAs (error bars indicate standard error from the mean and stars the degrees of significance from untreated controls––or between assays connected
by black lines). (A) Relative luciferase levels of Con1b luc trans:NS5B RNA in the presence of antisense-LNAs. (B) Relative luciferase levels of JFH-
1 luc trans:NS5B RNA in the presence of antisense-LNAs. (C) Relative luciferase levels of Con1b luc trans:NS5B RNA in the presence of antisense-
LNAs compared to variants in which the HCV 5′NCR was replaced with either a polio virus 5′NCR or m7G cap and a further monocistronic variant
lacking the EMCV IRES and upstream NS5B region.
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>70% (P ≤ 0.0001) respectively. As seen in the replication-
based assays, antisense-LNAs targeting the 5′ side of the
duplex stem of SL9266 (C 9263) or position 9110 (C 9106)
had no statistically significant impact on HCV IRES driven
translation. Additionally, we investigated translation and its
potential inhibition in non-hepatocyte human (HeLa) or
non-human (Vero) cell lines to determine whether the inhi-
bition seen was cell-type specific (Supplementary data S4).
LNA C 9284 (complementary to the single stranded loops
and upper duplex of SL9266; Figure 1C) similarly inhib-
ited translation in both cell types, though to a lesser extent
than seen in Huh 7.5 cells. The differences in translation in-
hibition from that observed in Huh 7.5 cells were weakly
significant (HeLa P = 0.0084 and Vero P = 0.0110).
The equilibrium between open and closed conforma-
tions of SL9266/PK in JFH-1 is biased towards forma-
tion of the closed structure (with the open conforma-
tion apparently favoured in genotype 1 Con1b and H77
viruses) (23). In order to determine whether this influ-
enced HCV IRES-mediated translation we compared the
luciferase signal generated from JFH-1 luc trans:NS5B
and Con1b luc trans:NS5B (Supplementary data S3).
They were statistically indistinguishable, though it should
be noted that – for reasons of compatibility between the
IRES and SL9266/PK sequences (28)––translation was
driven by different HCV IRES elements (derived from
the same genotype as the NS5B/3′NCR sequences in the
bicistronic vector), which may have obscured the influ-
ence of the conformation of SL9266/PK. We went on to
investigate LNA-mediated inhibition of translation from
bicistronic reporters containing JFH-1-derived sequences.
Broadly the patterns of inhibition were similar to that ob-
served with the Con1b-containing bicistronic system. How-
ever, although still statistically significant, relative inhibi-
tion levels were generally lower in the JFH-1 based sys-
tem (Figure 4B). The greatest inhibition of the JFH-1
HCV IRES (∼60%) was observed with LNA J 9282 (P
= 0.0004)––complementary to the single stranded loops
and 3′ components of the SL9266 upper duplex––which
was statistically indistinguishable from repression levels ob-
served when targeting the same regions of SL9266/PK in
Con1b luc trans:NS5B.
In order to investigate whether inhibition of trans-
lation was specific to the HCV IRES we tested fur-
ther bicistronic reporters, in which the HCV IRES of
Con1b luc trans:NS5B was replaced with the poliovirus
IRES or translation was driven from an RNA in which
an m7G ‘cap’ was added in vitro post-transcription (desig-
nated Polio-IRES luc trans and Con1b luc trans:5′NCR
respectively) (Figure 3). The effect on relative luciferase
translation from these RNA templates, when the terminal
and bulge loops of SL9266 were targeted with antisense-
LNAs (C 9280-9298), was assayed as described earlier (Fig-
ure 4C). Translation fromm7G 5′ capped transcripts was in-
hibited by∼20% (P= 0.0056) and from the Polio-IRES luc
trans by∼50% (P= 0.0035) (compared to>80% inhibition
from the Con1b IRES parallel assays). The >30% increase
in translational repression observed from the HCV IRES
compared to the polio IRES was statistically significant (P
= 0.001).
It has been suggested that translation from an upstream
HCV IRES in a bicistronic system is influenced––perhaps
by competition for cellular factors––by the presence of a
downstream IRES (21). To investigate if this was influ-
encing the translational repression observed in the cur-
rent study we additionally constructed a monocistronic
translation reporter (Figure 3). The transcript from this
Con1b containing plasmid––designated Con1b luc trans:
NS5B+EMCV––consisted of an upstream HCV IRES
initiating firefly luciferase translation, lacked the EMCV
IRES and following a stop codon incorporated the fi-
nal 1452 nts of the NS5B coding region and the en-
tire HCV 3′NCR. Following transfection of equimo-
lar amounts of Con1b luc trans: NS5B+EMCV or
Con1b luc trans:NS5B the luciferase signals obtained
were indistinguishable. Furthermore, the same level of
translational repression was observed in the presence of
LNA C 9280-9298 (>80%) (Figure 4C).
Genetic analysis of the SL9266/PK interaction on transla-
tion
We have previously published a combination of biochemi-
cal SHAPEmapping and analysis of replication phenotypes
showing that a G9583A substitution (in the terminal loop of
SL9571) prevents formation of SL9266/PK, locking it in
the open conformation and severely repressing HCV repli-
cation (∼3 log inhibition (23)). Conversely, introduction of
the double mutant of C9287U+ G9583A restores both the
ability of SL9266/PK to form the closed conformation and
wild-type levels of genome replication. To determine the in-
fluence thesemodifications have on translation theywere in-
troduced into Con1b luc trans:NS5B (Figure 5A). Trans-
lation was reduced to ∼66% of wild-type levels when the
closed conformation was prevented from forming by mu-
tation G9583A (P ≤ 0.0001) but then restored to wild-type
levels by the double substitution (mutant C9287U+G9583A).
Two further mutants were generated, incorporating substi-
tutions that disrupt SL9266/PK interactions demonstrated
in earlier studies (23,27) severely inhibit virus replication
(by ∼3 and ∼1.5 logs respectively) through either desta-
bilizing the upper duplex of SL9266 (A9275U+G9293U) or
bulge loop RNA-RNA interactions (C9302A), and trans-
lation levels compared to wild-type templates. Luciferase
signals were repressed by ∼20% (P = 0.0194) when the
base-paired stem of SL9266 was disrupted and were indis-
tinguishable from wild type when interactions of the sub-
terminal bulge loop were disrupted (Supplementary data
S5).
SL9266/PK in trans enhances translation
We have suggested that SL9266/PK may interact with cel-
lular or viral components during the temporal control of
the virus replication cycle (23). The bicistronic assay allows
quantification of translation in the absence of viral proteins.
We extended this investigation to study the consequences of
adding SL9266/PK in trans to this assay. Increasing concen-
trations of a non-translated NS5B-3′NCR transcript (see
M&M) were co-transfected with Con1b luc trans:NS5B
before luciferase activity was quantified at 6 h post-
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Figure 5. Translation in Huh 7.5 cells from SL9266/PK mutant
Con1b luc trans:NS5B RNA and the effect of adding mutant
SL9266/PK RNA in trans. Relative luciferase levels (Firefly/Renilla) were
measured 6 h post-transfection. Results represent the average of at least
three independent assays (error bars indicate standard error from themean
and stars the degrees of significance between assays connecting black
lines). (A) Relative luciferase levels of wild-type Con1b luc trans:NS5B
RNA compared to mutants in which the kissing loop of SL9266/PK was
either destroyed (G9583A) or restored (C9278U + G9583A). (B) Relative
luciferase levels of Con1b luc trans:NS5B RNA with increasing
concentrations of wild type (black unbroken line), SL9266/PK mutant
G9583A (black dashed line) or C9278U + G9583A (grey dashed line) RNA
added in trans. SL9266/PK trans concentrations increase from 0 to 1x and
5x molar excess. Results are expressed as a percentage of relative luciferase
levels with no trans SL9266/PK RNA.
transfection. Unmodified NS5B-3′NCR and variants bear-
ing either G9583A or C9287U+G9583A substitutions were
tested in parallel (Figure 5B). Wild-type SL9266/PK added
in trans significantly stimulated translation in a dose depen-
dent manner, with an ∼200% increase in translation at a 5x
molar excess. Compared towild-type SL9266/PK, amutant
transcript G9583A (locked in the open conformation) had
a significantly diminished effect, stimulating translation by
<50% at 5x molar excess. The extra stimulation observed
for the wild-type molecule compared to mutant G9583A was
significant at P = 0.0009. Wild-type levels of stimulation
were restored in a double mutant C9287U+G9583A, in which
ability to form the ‘kissing loop’ interaction was restored
(23).
DISCUSSION
The RNA genome of HCV is multifunctional, acting as a
template for negative strand synthesis, translation of the
polyprotein and a substrate for encapsidation into new vi-
ral particles. Following release into the cytosol the genome
is translated by host cell machinery before negative strand
synthesis generates the double-stranded replicative interme-
diates. In later stages of the replication cycle these are com-
partmentalized in membrane-associated replication com-
plexes (RCs), presumably thereby providing functional iso-
lation for themutually exclusive processes of replication and
translation. However, earlier in infection, before RCs are
formed, temporal control is required to avoid ribosomes
processing from the 5′ end of the genome clashing with the
viral polymerase complex involved in negative strand syn-
thesis (37). Where known in other virus systems, control
mechanisms often function through signals at the 5′ and
3′ ends of the genome, interacting with either host cell or
virally encoded factors mediated by RNA sequence and/or
structure-specific binding. Such interactions may also influ-
ence genome circularization, through which the proximity
of initiation and control determinants replicate and trans-
late the genome in an ordered manner. HCV genome cir-
cularization appears to be determined, at least in part, by
interaction with the poly C binding protein (PCBP2) (38).
In contrast, temporal control of the replication and trans-
lation processes has yet to be fully elucidated.
SL9266, one of several phylogenetically conserved stem–
loop structures in the 3′ region of the ORF, is a CRE essen-
tial for HCV replication (25,26). Structural and reverse ge-
netic studies have shown that SL9266 takes part in various
long distance RNA-RNA interactions forming pseudoknot
and ‘kissing loop’ structures; disruption of which block ef-
ficient virus replication (27–30,35). Previously, we demon-
strated that the critical SL9266/PK structure––formed by
a ‘kissing loop’ interaction between the terminal loops of
SL9266 and SL9571 within the X-tail of the 3′NCR––is
dynamic and undergoes structural re-arrangement between
open and closed conformations (23,31). The ability to adopt
both conformations was shown as essential for efficient
virus replication. We speculated that this structural rear-
rangement may represent anRNA switch (riboswitch), con-
trolling or modulating HCV translation and replication. In
the current study we investigated the role of SL9266/PK in
specifically modulating HCV translation.
Due to the exquisite complementarity of binding,
antisense-LNAs offer a means to inhibit and functionally
dissect the potentially different roles of both the structure
and domains of SL9266/PK; to achieve this a range of
antisense-LNAs were designed and their effect on HCV
replication assayed. Scrambled LNAs and those specific
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Figure 6. A schematic interpretation of SL9266/PK conformational re-
arrangement as part of a translation/replication switch; illustrating the
mechanism and role of negative feedback interactions in the proposed
model. The upper schematic illustrates up-regulation of HCV IRES ini-
tiated translation (large red arrow) due to the SL9266/PK closed confor-
mation sequestering a cellular IRES inhibition factor (IF). The lower car-
toon illustrates the open conformation, initiated by virally encoded non-
structural proteins (5A and 5B) binding the 3′NCR and blocking ‘kissing
loop’ formation. The open structure favours interaction between cellular
protein EWSR1 and SL9266, up-regulating RNA replication (large blue
arrow) (41). As demonstrated in the current study the resulting open con-
formation removes up-regulation of HCV translation (small red arrow),
which we speculate is due to EWRS1 displacing - and thus making avail-
able - translation inhibition factor IF.
for non-structured regions of the genome did not inhibit
virus replication. However, antisense-LNAs complemen-
tary to sequence motifs within SL9266/PK significantly in-
hibited replication of both the Con1b sub-genomic repli-
con and the J6/JFH-1 full-length virus. This concords
with previous studies showing that mutations destabiliz-
ing SL9266, SL9571 or SL9266/PK inhibit virus replica-
tion and that RNA aptamers against SL9266 inhibit repli-
cation in a sub-genomic assay (39). As inhibition was ob-
served in sub-genomic replicon systems––lacking the viral
structural proteins––we can presume that SL9266/PK has
a role in replication events prior to encapsidation, although
additional functions cannot be excluded.
In preliminary assays, we investigated whether disrup-
tion of SL9266/PK specifically impacts HCV IRES-driven
translation, using antisense-LNAs to investigate the pheno-
typic consequences of modulating the open or closed con-
formation. Relative inhibition levels of HCV IRES driven
translation were indistinguishable between wild type and
replication-defective (GDD>GND) Con1b sub-genomic
replicons; when simultaneously targeting the terminal and
bulge-loop of SL9266 or the bulge loop of SL9266 and ter-
minal loop of SL9571 (Figure 2C). As the reporter signal
generated by replication-defective mutants was reduced it
strongly suggests that reduction in translation accounts for
the inhibition of HCV genome replication.
To better quantify translation inhibition without the
confounding issue of genome replication we developed a
novel bicistronic reporter system in which luciferase ex-
pression, driven from the HCV 5′ NCR, could be tested
in the presence of mutations in SL9266/PK or interacting
antisense-LNAs. These studies further emphasised the im-
portance of the ‘kissing loop’ interaction in the modulation
ofHCV IRES-driven translation. Antisense-LNAs comple-
mentary to the terminal loops of either SL9266 or SL9571
(or both simultaneously) significantly inhibited translation
(Figure 4A and B)), thereby supporting the results obtained
using replication-defective sub-genomic replicons. Previous
studies have shown that mutations disrupting either the
duplex-stem of SL9266 or interaction of the sub-terminal
bulge loop and upstream sequences centred on nucleotide
9110 severely inhibit virus replication (at least in the Con1b
system) (25,27). However, antisense-LNAs designed to in-
teract with these regions had no influence on HCV replica-
tion (Figure 2A) or translation (Figure 4A and B). In quan-
tified gel binding assays antisense-LNAs targeting these re-
gions (C 9263 and C 9106) were shown to efficiently bind
the template (Supplementary data S2). We propose that
these apparently contradictory results may reflect LNA tar-
get inaccessibility, for example due to interaction of the
translation template with host proteins, or the template
adopting an inaccessible conformation in the cellular envi-
ronment.
Having demonstrated that blocking or disrupting
SL9266/PK inhibits HCV virus replication - at least in
part - due to a specific effect on virus translation, we
extended the study to examine whether this was specific to
HCV IRES driven translation or was mediated through
factors common to other modes of translation initiation
(Figure 4C). In modified translation only reporter systems
an antisense-LNA, complementary to both the terminal
and bulge loop of SL9266, inhibited HCV IRES driven
translation ∼2-fold more efficiently than for poliovirus
IRES initiated translation and ∼4-fold more efficiently
than m7G cap-dependent translation. The sub-terminal
bulge loop of SL9266 and domain IIId of the HCV
IRES include a six-nucleotide complementary motif (40).
Their demonstrated interaction in in vitro assays has been
suggested to indicate a role in modulation of translation
(28,40), although we have not found evidence to support
this model or interaction using SHAPE mapping and
reverse genetics (23). The fact that blocking SL9266/PK
significantly inhibits translation from both a m7G cap and
poliovirus IRES - although to a lesser degree than from the
HCV IRES - further suggests that SL9266/PK does not
act on translation through a direct RNA–RNA interaction
with the HCV IRES (the poliovirus IRES does not contain
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sequence motifs complementary to known interactions
of the bulge-loop of SL9266 using either canonical or
non-canonical pairing; data not shown). Additionally, in
the present study a C9302A substitution in the bulge loop of
SL9266 (disrupting the predicted IIId interaction) had no
effect on HCV IRES driven translation, further suggesting
that the SL9266-IIId interaction may not have a significant
role in translation control. (Supplementary data S5). In the
absence of evidence for a direct RNA–RNA interaction
modulating translation we speculated that SL9266/PK
could instead sequester a host trans-activating factor that
is normally inhibitory to IRES-mediated translation.
If SL9266/PKdoes sequester an inhibitory cellular factor
we reasoned that addition of an RNA bearing SL9266/PK
in trans should enhance reporter gene expression. This
proved to be the case, with a >2.5-fold stimulation of the
HCV IRES and no effect on m7G cap initiated translation
(Figure 5B). Furthermore, the stimulatory affect of trans
addition of SL9266/PK in the native conformation (either
unmodified or with covariant C9287U and G9583A substi-
tutions) was ∼2-fold more effective than the open confor-
mation (mutant G9583A). This suggests that it is the native
conformation -a dynamic structure able to form the ‘kissing
loop’ interaction - that is functionally important. It further
implies that translation is stimulated by a predominantly
structure-dependent mechanism, rather than being deter-
mined by the precise and highly conserved sequence at the
terminal loops of SL9266 and SL9571 (30).
Here, we propose a model in which the closed conforma-
tion of SL9266/PK favours translation of the virus genome
by an as-yet undetermined mechanism that may involve re-
cruitment of one or more inhibitory cellular factors. Con-
versely, the open conformation - in which the ‘kissing loop’
interaction is absent and SL9571 is instead able to adopt a
stem–loop structure (23) - favours replication (41). Interest-
ingly, the cellular protein EWSR1 has recently been shown
to enhance HCV replication through preferential interac-
tion with SL9266 in the open conformation (41). In amodel
proposed by Oakland et al. (41), the switch from translation
to replication involved disruption of the ‘kissing loop’ inter-
action, favouring recruitment of EWSR1 and initiation of
replication. What remains unclear from these related mod-
els is whether a feedback mechanism exists that represses
translation - for example, after sufficient non-structural pro-
teins have been synthesised - to enable genome replication.
We speculate that such a feedback mechanism may func-
tion through the interaction of SL9266/PK with virally
encoded non-structural proteins. Non-structural proteins
NS5A - critical for efficient virus replication (42,43) - and
NS5B both bind the virus 3′UTR (44,45); NS5A to the
poly U/UC tract (46) and NS5B to the X-tail (46). They
have also been shown to interact with each other, modu-
lating negative-strand synthesis (43,47,48). We hypothesize
that by binding in the region of SL9571, NS5A and 5B ini-
tiate a negative feedback to HCV translation by blocking
formation of the ‘kissing loop’, resulting in stabilization of
SL9266/PK in the open-conformation thus favouring bind-
ing of EWSR1 to SL9266 and consequently up-regulating
genome replication (Figure 6). In the current study, expres-
sion of NS5B in cis had no affect on HCV translation or
antisense-LNA inhibition (Supplementary data S3). This is
consistent with the suggestion that both NS5A and 5B may
be required, acting in concert to stimulate replication (46).
A logical extension of this model would be that their re-
cruitment inhibits the interaction of SL9266/PK with the
proposed translational inhibitory factor. A consequence of
this would be translation suppression at the same time as
genome replication is initiated (Figure 6).
The relationship between the structural complexity and
multi-functional nature of the RNA genome of HCV is
gradually being elucidated. The studies presented here pro-
pose a model within which the temporal control of repli-
cation events and the contribution made by viral and cellu-
lar proteins can be investigated. These studies are important
both for our understanding ofHCVand related viruses and,
since they are likely to be evolutionary conserved features in
what are otherwise highly variable viruses, provide potential
targets for therapeutic intervention.
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